AstraZeneca trials Farxiga as potential treatment for COVID-19 patients

11:45pm PDT - April 22nd, 2020    astrazeneca - Reuters

AstraZeneca said on Thursday it has begun a late-stage trial to test if its diabetes drug Farxiga can reduce the risk of serious complications and organ failure in COVID-19 patients who have existing heart and kidney problems.